Literature DB >> 17684733

Behavioural and neurochemical effects of combined MDMA and THC administration in mice.

Patricia Robledo1, Jose M Trigo, Fany Panayi, Rafael de la Torre, Rafael Maldonado.   

Abstract

RATIONALE: Cannabis is the most widely consumed drug associated with 3,4-methylenedioxymethamphetamine (MDMA) use.
OBJECTIVES: This study examines whether low doses of MDMA and delta-9-tetrahydrocannabinol (THC) produce synergistic rewarding/reinforcing effects in mice using the conditioned place preference (CPP) and operant self-administration paradigms. Changes in dopamine (DA) outflow were monitored in the nucleus accumbens (NAC) after single or combined administration of these compounds.
RESULTS: MDMA induced a significant CPP at the dose of 10 mg/kg but not at the dose of 3 mg/kg. THC (0.3 mg/kg) by itself was also ineffective in this paradigm. The combined administration of the low dose of MDMA (3 mg/kg) and THC (0.3 mg/kg) produced CPP, whereas the combination of MDMA (10 mg/kg) and THC (0.3 mg/kg) significantly decreased CPP. Animals treated with THC self-administered a sub-threshold dose of MDMA (0.06 mg/kg per infusion), while animals receiving vehicle did not. However, THC did not modify the self-administration of an effective dose of MDMA (0.125 mg/kg per infusion). In microdialysis studies, a low dose of THC significantly increased DA outflow in the NAC, while a low dose of MDMA did not. When MDMA was administered before THC, DA levels decreased with respect to THC. However, when THC was administered before MDMA, DA levels were not significantly modified with respect to THC.
CONCLUSIONS: These results demonstrate that a low dose of THC modifies in different ways (increases and decreases) the sensitivity of animals to the behavioural effects of MDMA and that THC and MDMA converge at a common mechanism modulating DA outflow in the NAC of mice.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17684733     DOI: 10.1007/s00213-007-0879-8

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  32 in total

1.  Role of the endocannabinoid system in MDMA intracerebral self-administration in rats.

Authors:  Daniela Braida; Mariaelvina Sala
Journal:  Br J Pharmacol       Date:  2002-08       Impact factor: 8.739

2.  Lack of CB1 cannabinoid receptor impairs cocaine self-administration.

Authors:  Guadalupe Soria; Victoria Mendizábal; Clara Touriño; Patricia Robledo; Catherine Ledent; Marc Parmentier; Rafael Maldonado; Olga Valverde
Journal:  Neuropsychopharmacology       Date:  2005-09       Impact factor: 7.853

3.  Pathways into ecstasy use: the role of prior cannabis use and ecstasy availability.

Authors:  Petra Zimmermann; Hans-Ulrich Wittchen; Florian Waszak; Agnes Nocon; Michael Höfler; Roselind Lieb
Journal:  Drug Alcohol Depend       Date:  2005-09-01       Impact factor: 4.492

4.  Behavioural and biochemical evidence for interactions between Delta 9-tetrahydrocannabinol and nicotine.

Authors:  Emmanuel Valjent; Jennifer M Mitchell; Marie-Jo Besson; Jocelyne Caboche; Rafael Maldonado
Journal:  Br J Pharmacol       Date:  2002-01       Impact factor: 8.739

5.  Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism.

Authors:  G Tanda; F E Pontieri; G Di Chiara
Journal:  Science       Date:  1997-06-27       Impact factor: 47.728

Review 6.  The effects of methylenedioxymethamphetamine (MDMA, "Ecstasy") on monoaminergic neurotransmission in the central nervous system.

Authors:  S R White; T Obradovic; K M Imel; M J Wheaton
Journal:  Prog Neurobiol       Date:  1996-08       Impact factor: 11.685

7.  Modulation by fluoxetine of striatal dopamine release following Delta9-tetrahydrocannabinol: a microdialysis study in conscious rats.

Authors:  D T Malone; D A Taylor
Journal:  Br J Pharmacol       Date:  1999-09       Impact factor: 8.739

8.  A behavioural model to reveal place preference to delta 9-tetrahydrocannabinol in mice.

Authors:  E Valjent; R Maldonado
Journal:  Psychopharmacology (Berl)       Date:  2000-01       Impact factor: 4.530

9.  3,4-methylenedioxymethamphetamine self-administration is abolished in serotonin transporter knockout mice.

Authors:  José Manuel Trigo; Thibault Renoir; Laurence Lanfumey; Michel Hamon; Klaus-Peter Lesch; Patricia Robledo; Rafael Maldonado
Journal:  Biol Psychiatry       Date:  2007-02-16       Impact factor: 13.382

10.  Self-administration of methylenedioxymethamphetamine (MDMA) by rhesus monkeys.

Authors:  P M Beardsley; R L Balster; L S Harris
Journal:  Drug Alcohol Depend       Date:  1986-10       Impact factor: 4.492

View more
  14 in total

1.  Δ9-tetrahydrocannabinol and endocannabinoid degradative enzyme inhibitors attenuate intracranial self-stimulation in mice.

Authors:  Jason M Wiebelhaus; Travis W Grim; Robert A Owens; Matthew F Lazenka; Laura J Sim-Selley; Rehab A Abdullah; Micah J Niphakis; Robert E Vann; Benjamin F Cravatt; Jenny L Wiley; S Stevens Negus; Aron H Lichtman
Journal:  J Pharmacol Exp Ther       Date:  2014-11-14       Impact factor: 4.030

2.  Behavioral and neurochemical effects of repeated MDMA administration during late adolescence in the rat.

Authors:  Brittney M Cox; Mrudang M Shah; Teri Cichon; Manuel E Tancer; Matthew P Galloway; David M Thomas; Shane A Perrine
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2013-10-10       Impact factor: 5.067

3.  Methylphenidate Attenuates the Cognitive and Mood Alterations Observed in Mbnl2 Knockout Mice and Reduces Microglia Overexpression.

Authors:  Carla Ramon-Duaso; Thomas Gener; Marta Consegal; Cristina Fernández-Avilés; Juan José Gallego; Laura Castarlenas; Maurice S Swanson; Rafael de la Torre; Rafael Maldonado; M Victoria Puig; Patricia Robledo
Journal:  Cereb Cortex       Date:  2019-07-05       Impact factor: 5.357

4.  Chronic administration of THC prevents the behavioral effects of intermittent adolescent MDMA administration and attenuates MDMA-induced hyperthermia and neurotoxicity in rats.

Authors:  Erica Y Shen; Syed F Ali; Jerrold S Meyer
Journal:  Neuropharmacology       Date:  2011-07-13       Impact factor: 5.250

5.  The safety of modafinil in combination with oral ∆9-tetrahydrocannabinol in humans.

Authors:  Dawn E Sugarman; James Poling; Mehmet Sofuoglu
Journal:  Pharmacol Biochem Behav       Date:  2010-12-21       Impact factor: 3.533

6.  Cannabinoid conditioned reward and aversion: behavioral and neural processes.

Authors:  Jennifer E Murray; Rick A Bevins
Journal:  ACS Chem Neurosci       Date:  2010-03-10       Impact factor: 4.418

7.  Effect of the CB1 cannabinoid agonist WIN 55212-2 on the acquisition and reinstatement of MDMA-induced conditioned place preference in mice.

Authors:  Carmen Manzanedo; Marta Rodríguez-Arias; Manuel Daza-Losada; Concepción Maldonado; María A Aguilar; José Miñarro
Journal:  Behav Brain Funct       Date:  2010-03-22       Impact factor: 3.759

8.  THC Prevents MDMA Neurotoxicity in Mice.

Authors:  Clara Touriño; Andreas Zimmer; Olga Valverde
Journal:  PLoS One       Date:  2010-02-10       Impact factor: 3.240

9.  Differential changes in mesolimbic dopamine following contingent and non-contingent MDMA self-administration in mice.

Authors:  María Juliana Orejarena; Fernando Berrendero; Rafael Maldonado; Patricia Robledo
Journal:  Psychopharmacology (Berl)       Date:  2009-06-04       Impact factor: 4.530

Review 10.  Emerging strategies for exploiting cannabinoid receptor agonists as medicines.

Authors:  Roger G Pertwee
Journal:  Br J Pharmacol       Date:  2009-02       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.